BAFF antibody
Quick Overview for BAFF antibody (ABIN217771)
Target
See all BAFF (TNFSF13B) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Specificity
- Recognizes CD257 (otherwise known as BAFF/BLyS), a 285 amino acid type II transmembrane protein and member of the tumor necrosis factor (TNF) superfamily of ligands, which acts as a B and T cell stimulator and plays a role in the development of autoimmune diseases such as systemic lupus erythematosus. CD257 is expressed by monocytes, macrophages, T cells and dendritic cells and acts through binding to CD267 (TACI), CD269 (BCMA) and CD268 (BAFFR) receptors, the latter interaction playing a critical role in the activation, survival, differentiation and proliferation of B cells.
-
Purification
- Protein A purified
-
Immunogen
-
Recombinant human CD257.
Type of Immunogen: Recombinant protein -
Isotype
- IgG1
-
-
-
-
Application Notes
- Approved: ELISA (5 - 6 μg/mL)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Distilled Water.
-
Concentration
- Lot specific
-
Buffer
- Lyophilized, PBS, pH 7.2.
-
-
- BAFF (TNFSF13B) (Tumor Necrosis Factor (Ligand) Superfamily, Member 13b (TNFSF13B))
-
Alternative Name
- BAFF
-
Background
-
Name/Gene ID: TNFSF13B
Family: TNF
Synonyms: TNFSF13B, B-cell-activating factor, BAFF, ApoL related ligand TALL-1, B-lymphocyte stimulator, CD257, BLYS, Delta4 BAFF, Delta BAFF, TALL-1, TALL1, ZTNF4, THANK, B lymphocyte stimulator, CD257 antigen, TNFSF20 -
Gene ID
- 10673
-
UniProt
- Q9Y275
-
Pathways
- NF-kappaB Signaling, Production of Molecular Mediator of Immune Response
Target
-